Orphan medicinal products

 

Cases suffering from rare diseases earn the same quality of medication as other cases. Given the small number of cases affected by rare conditions, the pharmaceutical assiduity has been reticent in the history to invest in the disquisition and development of medicinal products to treat them and Orphan medicinal products are intended for the opinion, forestalment or treatment of life- hanging or veritably serious conditions that affect no further than 5 in 10,000 people.

Orphan medicinal products:

    Related Conference of Orphan medicinal products

    September 22-23, 2025

    6th World Congress on Neuroimmunology and Neuroinfectious Diseases

    Amsterdam, Netherlands
    October 16-17, 2025

    39th International Conference on Immunology

    Amsterdam, Netherlands
    May 18-19, 2026

    17th Global Summit on Immunology and Cell Biology

    Paris, Aland Islands

    Orphan medicinal products Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in